...
机译:血栓调节蛋白ALFA通过促进蛋白C活化来衰减细胞外组蛋白的促凝血效应和细胞毒性
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Department of Pathology and Pharmacology Loyola University Medical Center;
Laboratory for Pharmacology Pharmaceuticals Research Center Asahi Kasei Pharma Corporation;
Thrombomodulin; Histones; Protein C; Thrombin; Cell death;
机译:血栓调节蛋白ALFA通过促进蛋白C活化来衰减细胞外组蛋白的促凝血效应和细胞毒性
机译:血栓调节素α和活化蛋白C在体外凝血和纤溶中的药理学差异
机译:血栓调节素ALFA和活化蛋白C在体外凝血和纤维蛋白溶解的药理分化
机译:低功率激光照射(LPLI)通过激活Src途径减轻小胶质细胞毒性
机译:组蛋白H4仅通过C反应蛋白和表面活性剂蛋白-D反击,仅激活嗜中性粒细胞或具有流感病毒
机译:重组人可溶性血栓调节蛋白与通过抑制细胞外组蛋白释放的败血症诱导的肾损伤的衰减有关
机译:蛋白C抑制剂通过抑制人血浆中蛋白C的蛋白C激活而作用作为探测剂